Skip to main content
Peter MacCallum Cancer Centre
  • Donate
  • Location
  • Search
  • English
  • Easy English
  • العَرَبِيَّة Arabic
  • 中文 Chinese
  • Eλληνικά Greek
  • हिन्दी Hindi
  • Italiano Italian
  • Tagalog Tagalog
  • Türkçe Turkish
  • Tiếng Việt Vietnamese
  • About
  • Profiles
  • Careers
  • Education
  • News
  • Events
  • Get involved
  • Contact
  • Cancer types
    • Breast
    • Upper Gastrointestinal
    • Lower Gastrointestinal
    • Genitourinary Oncology
    • Gynae-oncology
    • Clinical Haematology
    • Head & neck
    • Lung
    • Melanoma & Skin
    • Neuro-oncology
    • Paediatric
    • Sarcoma
    • Cancer of unknown primary
  • Our services
    • Diagnosis & investigations
    • Treatment
    • Support services
    • Cancer information & resources
  • Coming to Peter Mac
    • Melbourne
    • Bendigo
    • Box Hill
    • Moorabbin
    • Sunshine
    • Telehealth
  • Research & discovery
    • Clinical research
    • Research laboratories
    • CoE Cellular Immunotherapy
    • Core facilities
    • ProsTIC
    • Research cohort studies
    • Research programs
    • Doing research with us
    • Commercialisation, partnerships and industry engagement
    • Publications
    • Research strategy
    • Education in research
    • Biomedical Animation
    • National Particle Therapy Symposium
    • Use your cancer experience to help guide research
  • Clinical Trial Care
    • Patients and Families
    • Health Professionals
    • Clinical Trial Sponsors
  1. Home
  2. Profiles
  3. Dr Ashish Bajel
Consultant Haematologist; Haematologist and Disease Group Lead; Acute Leukemia and Myelodysplastic Syndromes

Dr Ashish Bajel

Haematology

Biography

Dr Ashish Bajel is a clinical Haematologist, BMT physician and the stream lead for acute leukemia and MDS at the VCCC.  He has expertise in treating a range of benign and malignant haematological conditions. with  special interest in  acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms and bone marrow transplants. He oversees the umbilical cord blood transplant and haplo-identical bone marrow transplant programs at the VCCC. Dr Bajel is the member of scientific committees in the Australasian Leukemia and Lymphoma Group (ALLG)  and CIBMTR. He is committed to clinical and translational research aimed at developing new treatments for leukemias and myeloproliferative disorders. Dr Bajel has published  in numerous peer reviewed journals.

Related Links

Haematology
Acute Leukemia and Myelodysplasia
Allogeneic Transplantation
Myeloma and Autologous Stem Cell Transplantation
Myeloproliferative Diseases

Qualifications

MBBS, FRACP, FRCPA

Publications

Lim AB, Roberts AW, Mason K, Bajel A, Szer J, Ritchie DS. Validating the allogeneic stem cell transplantation disease risk index: sample size, follow-up, and local data are important. Transplantation. 2015 Jan;99(1):128-32

Thompson PA, Lim A, Panek-Hudson Y, Tacey M, Hijazi R, Ng AP, Szer J, Ritchie D, Bajel A. Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Jun;20(6):781-6.

Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Moore J, Schwarer AP, Guy S, Bajel A, Tramontana AR, Spelman T, Slavin MA; Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group.Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis. 2013 Jun;13(6):519-28.

Mathews V, George B, Lakshmi KM, Viswabandya A, Bajel A, Balasubramanian P, Shaji RV, Srivastava VM, Srivastava A, Chandy M. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood. 2006 Apr 1;107(7):2627-32

Ashish Bajel's complete list of publications

Consultant Haematologist; Haematologist and Disease Group Lead; Acute Leukemia and Myelodysplastic Syndromes

Dr Ashish Bajel

Haematology

Peter MacCallum Cancer Centre

  • Victorian Comprehensive Cancer Centre building
    305 Grattan Street
    Melbourne VIC 3000
    Australia
    Peter MacCallum Cancer Centre
  • (03) 8559 5000 (In an emergency, call 000)
  • (03) 8559 7379 (Main fax)
  • (03) 8559 7371 (Referrals fax)
  • Locations
    • Melbourne
    • Bendigo
    • Box Hill
    • Moorabbin
    • Sunshine
  • About us
    • Get involved
    • Upcoming events
    • Partnerships
    • Patient charter
  • Cancer types
  • Cancer services
    • Diagnosis & investigations
    • Treatments
    • Cancer info & resources
  • Refer your patient
  • Peter MacCallum Cancer Foundation
  • Australian Cancer Survivorship Centre
  • Research & discovery
    • Clinical research & trials
    • Research cohort studies
    • Research labs
  • Careers
  • Education

Our Community

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Contact us
Comments & feedback

The Peter MacCallum Cancer Centre acknowledges the traditional owners of the land on which our five sites are located throughout Victoria. We recognise their strength and resilience and pay our respects to their Elders past and present.

Languages
Auslan
Interpreter
Site by Icon Agency
  • Privacy policy
  • Terms & Conditions
  • Intranet